Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
Tickers NEWS RHHBY TPST
Tags Movers Market News Small Cap
From Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
Tickers LLY NVO RHHBY
Tags Recent Press Releases LLY Market News
From Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Tickers ABBV BMY NEWS RHHBY
Tags Benzinga Top Stories General
From Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
Tickers MRK NEWS RHHBY
Tags Biotech RHHBY MRK
From Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
Tickers AMGN LLY NVO PFE
Tags VKTX Recent Press Releases AMGN
From Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
Tickers C GOOG GOOGL NEWS
Tags News Large Cap M&A
From Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
Tickers AGEN BMY MRK NEWS
Tags why it's moving General Benzinga
From Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
Tickers ALT LLY NVO PFE
Tags PFE ALT LLY
From Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
Tickers LLY NVO RHHBY
Tags Recent Press Releases LLY NVO
From Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Tickers LLY NEWS NVO PFE
Tags Benzinga General Biotech
From Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
Tickers LLY NVO RHHBY
Tags NVO RHHBY Market News
From Motley Fool
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
Tickers LLY NEWS NVO PFE
Tags Benzinga General AI Generated
From Benzinga
This Big Pharma Could Become a Leading Weight-Loss Stock. Should You Buy It?
Tickers RHHBY
Tags Recent Press Releases RHHBY Market News
From Motley Fool
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
Tickers PFE RHHBY
Tags PFE Market News RHHBY
From Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Tickers AMGN AZN HRTS LLY
Tags weight/loss glp/1 Benzinga
From Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
Tickers AA ABT ALK BX
Tags Health Care Econ #s $BTC
From Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Tickers LLY NVO RHHBY
Tags Market News NVO RHHBY
From Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
Tickers LLY NEWS NVO PFE
Tags contributors General Benzinga
From Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
Tickers GPCR LLY NEWS NVO
Tags News Large Cap LLY
From Benzinga
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
Tickers NEWS RHHBY
Tags Large Cap News Health Care
From Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
Tickers AMGN BAYRY CHPT EXAI
Tags VRDN Stocks to Buy RHHBY
From InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
Tickers MRK NEWS RHHBY
Tags Market News Briefs Large Cap
From Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
Tickers ABBV BNTX GMAB JNJ
Tags BNTX Market News JNJ
From Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
Tickers AZN GEHC JNJ NEWS
Tags Health Care Legal News
From Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Tickers AMGN AZN BMY GILD
Tags JNJ Briefs BMY
From Benzinga
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
Tickers RHHBY SRPT
Tags Today's Market SRPT RHHBY
From InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
Tickers NEWS PFE RGNX RHHBY
Tags Briefs SRPT Movers
From Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
Tickers ABBV FDMT NEWS REGN
Tags Trading Ideas News RGNX
From Benzinga
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
Tickers NEWS NVS RHHBY
Tags Media Top Stories Benzinga
From Benzinga
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
Tickers ARKG ARKK DNA RHHBY
Tags ARKK ARKG Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.